Aeromonas salmonicida (Furunculosis)
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Aeromonas salmonicida is a Gram-negative, non-motile bacterium responsible for furunculosis, a systemic and often fatal disease affecting a broad range of fish species, including salmonids, turbot, and sturgeon.
- Virulence is mediated by a multifaceted arsenal including the A-layer (S-layer) for adhesion and immune evasion, type III and VI secretion systems for host cell manipulation, and extracellular enzymes like proteases and hemolysins that degrade host tissues.
- Diagnosis relies on characteristic clinical signs (furuncles, septicemia), bacteriological culture yielding pigmented colonies, biochemical profiling, and molecular methods such as PCR targeting specific genes (e.g., vapA) or whole-genome sequencing for strain characterization.
- Control strategies encompass vaccination (commercial or autogenous), judicious antimicrobial therapy guided by susceptibility testing to combat emerging resistance, stringent biosecurity measures, and the exploration of novel approaches like phage therapy and quorum sensing inhibitors.
- Furunculosis presents in peracute (sudden mortality), acute (septicemia, hemorrhages), and chronic (furuncle formation) forms, with pathogenesis involving initial adhesion to epithelia, invasion, and rapid systemic dissemination.
- Host immune responses involve innate and adaptive mechanisms, with studies revealing impairments in lysosomal and apoptotic pathways in macrophages, and differential expression of immune-related genes in affected fish tissues.
Introduction
Aeromonas salmonicida is a Gram-negative, non-motile, facultatively anaerobic bacterium that is the primary etiological agent of furunculosis, a systemic and often fatal disease of salmonid and non-salmonid fish species [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease is characterized by the formation of furuncles (boil-like lesions) in the musculature, although peracute and acute forms without external lesions are common [<a href="#ref-3">3</a>]. The pathogen has a broad host range that includes Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), turbot (Scophthalmus maximus), sturgeon (Acipenser baerii), and other freshwater and marine fish [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Isolates have also been recovered from non-fish hosts including pigs and cattle, indicating a wider ecological distribution than previously recognized [<a href="#ref-1">1</a>, <a href="#ref-7">7</a>]. This article provides a comprehensive review of the taxonomy, virulence mechanisms, pathogenesis, host immune responses, diagnostic approaches, and control strategies for A. salmonicida and furunculosis.
Taxonomy and Subspecies Diversity
Aeromonas salmonicida belongs to the family Aeromonadaceae within the class Gammaproteobacteria [<a href="#ref-8">8</a>]. The species is divided into several subspecies, including A. salmonicida subsp. salmonicida (the typical furunculosis agent), A. salmonicida subsp. masoucida, A. salmonicida subsp. achromogenes, and A. salmonicida subsp. oncorhynchi [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. Subspecies differentiation is based on biochemical profiles, growth characteristics, and genomic content [<a href="#ref-10">10</a>]. The typical subspecies (salmonicida) is considered the most virulent and is responsible for classical furunculosis in salmonids [<a href="#ref-8">8</a>]. Atypical subspecies, such as A. salmonicida subsp. achromogenes, are associated with chronic or ulcerative disease in a wider range of fish species [<a href="#ref-6">6</a>]. Genomic and pangenomic analyses have revealed substantial genetic diversity within the species, with mobile genetic elements and genomic islands contributing to strain-specific virulence and antimicrobial resistance profiles [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>].
Etiology and Biophysical Characteristics
A. salmonicida is a non-motile, Gram-negative rod measuring approximately 1.0 to 3.5 micrometers in length and 0.5 to 1.0 micrometer in width [<a href="#ref-3">3</a>]. The bacterium is a facultative anaerobe that grows optimally at temperatures between 20 and 25 degrees Celsius, although strain-dependent thermoadaptation has been documented [<a href="#ref-12">12</a>]. The organism produces a brown, water-soluble pigment on tryptic soy agar, a key phenotypic feature used in preliminary identification [<a href="#ref-3">3</a>]. The cell envelope contains a lipopolysaccharide (LPS) layer, a thin peptidoglycan layer, and an outer membrane that houses various virulence-associated proteins [<a href="#ref-13">13</a>]. A. salmonicida produces several extracellular products (ECPs) including proteases, hemolysins, and leukocidins that contribute to tissue damage and immune evasion [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>]. The bacterium also secretes outer membrane vesicles (OMVs) that contain GroEL chaperone proteins and other immunomodulatory molecules [<a href="#ref-13">13</a>]. These OMVs have been shown to inhibit biofilm formation by competing bacteria such as Pseudomonas fluorescens [<a href="#ref-14">14</a>].
Virulence Factors and Pathogenesis
The virulence arsenal of A. salmonicida is multifaceted and includes surface-associated factors, secreted enzymes, and regulatory systems. The A-layer, a paracrystalline surface protein array (S-layer), is a critical virulence determinant that mediates adhesion to host cells and provides protection against complement-mediated lysis [<a href="#ref-8">8</a>]. The type III secretion system (T3SS) is a needle-like apparatus that injects effector proteins directly into host cell cytoplasm, disrupting cytoskeletal dynamics and apoptotic pathways [<a href="#ref-16">16</a>]. The type VI secretion system (T6SS) is also present in many strains and contributes to interbacterial competition and host cell manipulation [<a href="#ref-8">8</a>].
Extracellular enzymes include a 70-kDa serine protease (P1) and a 20-kDa metalloprotease (P2) that degrade host connective tissues and facilitate systemic dissemination [<a href="#ref-15">15</a>]. A. salmonicida also produces a GCAT (glycerophospholipid:cholesterol acyltransferase) that acts as a hemolysin and leukocidin [<a href="#ref-14">14</a>]. The bacterium produces a melanin-like pigment that has immunomodulatory effects on Atlantic salmon macrophages, altering respiratory burst activity and cytokine expression [<a href="#ref-17">17</a>]. Quorum sensing (QS) systems, including the AhyI/AhyR homologs, regulate the expression of virulence factors in a cell-density-dependent manner [<a href="#ref-18">18</a>]. Resveratrol has been shown to block QS-mediated virulence phenotypes in A. salmonicida isolated from sturgeon [<a href="#ref-18">18</a>].
Cold shock proteins, particularly CspA, play a role in the physiology and virulence of A. salmonicida subsp. salmonicida, enabling the bacterium to adapt to low-temperature environments common in aquaculture settings [<a href="#ref-19">19</a>]. Strain-dependent thermoadaptation has been observed, with some strains maintaining virulence at temperatures above 25 degrees Celsius [<a href="#ref-12">12</a>]. Mobile genomic islands, such as GEI-FN1A, contribute to the spread of antibiotic resistance genes among A. salmonicida populations [<a href="#ref-11">11</a>].
Host Range and Clinical Presentation
A. salmonicida infects many fish species, including Atlantic salmon, rainbow trout, brown trout (Salmo trutta fario), turbot, sturgeon, grass carp (Ctenopharyngodon idella), and large yellow croaker [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-20">20</a>, <a href="#ref-21">21</a>, <a href="#ref-22">22</a>]. The bacterium has also been isolated from mammals, including pigs and cattle, although the clinical significance in these hosts remains under investigation [<a href="#ref-1">1</a>, <a href="#ref-7">7</a>]. A case of A. salmonicida peritonitis in a human undergoing peritoneal dialysis has been reported, but this is considered an opportunistic infection in an immunocompromised host [<a href="#ref-23">23</a>].
Furunculosis presents in peracute, acute, and chronic forms. Peracute disease causes sudden mortality without premonitory signs [<a href="#ref-3">3</a>]. Acute disease is characterized by septicemia, lethargy, anorexia, darkening of the skin, and hemorrhages at the base of fins [<a href="#ref-3">3</a>]. Chronic disease is marked by the formation of furuncles, which are necrotic, liquefactive lesions in the epaxial musculature that rupture to the surface [<a href="#ref-6">6</a>]. In turbot, chronic aeromoniasis has been associated with epibiotic green algae (Ulva spp.) on the skin [<a href="#ref-6">6</a>]. Co-infection with Flavobacterium psychrophilum in rainbow trout results in synergistic increases in mortality and more severe pathophysiological alterations compared to single infections [<a href="#ref-24">24</a>].
Pathogenesis and Host Immune Responses
The pathogenesis of furunculosis begins with bacterial adhesion to the gill epithelium or skin, followed by invasion of the underlying tissues and entry into the bloodstream [<a href="#ref-25">25</a>]. A. salmonicida infection inhibits mucin production in rainbow trout gills, compromising the mucosal barrier and facilitating bacterial entry [<a href="#ref-25">25</a>]. Once in the bloodstream, the bacterium multiplies rapidly, causing a fulminant septicemia [<a href="#ref-3">3</a>].
The host immune response to A. salmonicida involves both innate and adaptive components. In Atlantic salmon primary macrophages, dual-seq transcriptomics has revealed that infection induces lysosomal and apoptotic impairments, allowing the bacterium to survive intracellularly [<a href="#ref-16">16</a>]. In turbot, liver transcriptome analysis has shown that multiple immune processes and lipid metabolism pathways are involved in the defense response [<a href="#ref-4">4</a>]. In brown trout, transcriptome and resequencing studies have identified immune-related genes and molecular markers associated with resistance to A. salmonicida [<a href="#ref-20">20</a>]. The septin gene family in rainbow trout is differentially expressed in response to A. salmonicida infection, suggesting a role in cytoskeletal remodeling during the immune response [<a href="#ref-26">26</a>].
Probiotic supplementation with Lactiplantibacillus plantarum has been shown to modulate the immune response and improve survival in rainbow trout challenged with A. salmonicida [<a href="#ref-27">27</a>]. Similarly, gamma-irradiated Bifidobacterium longum subsp. infantis enhances immune modulation and resistance to furunculosis in rainbow trout [<a href="#ref-28">28</a>]. Functional feeds containing immunomodulatory ingredients have been evaluated for their ability to mitigate the effects of A. salmonicida outbreaks [<a href="#ref-29">29</a>]. Agaricus bisporus polysaccharides have been shown to alleviate A. salmonicida-induced enteritis in crayfish through modulation of the intestinal microbiota and immune gene expression [<a href="#ref-30">30</a>].
Diagnostic Approaches
Diagnosis of furunculosis is based on clinical signs, gross pathology, histopathology, and laboratory confirmation of the causative agent. Standard bacteriological culture involves isolation of the organism from kidney, spleen, or furuncle material on tryptic soy agar or brain heart infusion agar [<a href="#ref-3">3</a>]. Colonies are typically small, convex, and produce a brown diffusible pigment after 48 to 72 hours of incubation at 22 degrees Celsius [<a href="#ref-3">3</a>].
Biochemical identification is based on the following characteristics: Gram-negative rod, non-motile, oxidase-positive, catalase-positive, and fermentative metabolism of glucose [<a href="#ref-3">3</a>]. Molecular diagnostics include PCR targeting the 16S rRNA gene, the aroA gene, or the vapA gene encoding the A-layer protein [<a href="#ref-8">8</a>]. High-throughput sequencing approaches, including nanopore genome sequencing, have been used to characterize A. salmonicida strains from diseased sturgeon [<a href="#ref-5">5</a>]. Whole-genome sequencing and pangenomic analyses provide detailed insights into virulence gene content, antimicrobial resistance determinants, and phylogenetic relationships [<a href="#ref-8">8</a>, <a href="#ref-10">10</a>].
Serological methods, including ELISA and agglutination tests, can detect antibodies against A. salmonicida in fish sera, although these are more commonly used for research purposes than for routine diagnosis [<a href="#ref-2">2</a>]. Histopathology reveals necrotic muscle tissue with bacterial aggregates, hemorrhage, and inflammatory cell infiltration [<a href="#ref-3">3</a>].
The following table summarizes the key diagnostic methods for A. salmonicida:
| Method | Target | Sensitivity | Specificity | Application |
|---|---|---|---|---|
| Bacterial culture | Viable cells | Moderate | High | Routine isolation |
| Biochemical profiling | Metabolic enzymes | Moderate | Moderate | Preliminary identification |
| PCR (16S rRNA, aroA, vapA) | DNA | High | High | Confirmatory diagnosis |
| Whole-genome sequencing | Genomic DNA | Very high | Very high | Strain typing, AMR profiling |
| Histopathology | Tissue architecture | Moderate | Moderate | Lesion characterization |
| Serology (ELISA) | Antibodies | Moderate | Moderate | Research, surveillance |
Control and Prevention
Control of furunculosis relies on a combination of biosecurity measures, vaccination, antimicrobial therapy, and immunomodulatory feed additives. Vaccination is the most effective long-term strategy for preventing disease in farmed salmonids. Combined vaccines against vibriosis and typical and atypical furunculosis have been developed and shown to be effective in Atlantic salmon [<a href="#ref-2">2</a>]. Autogenous vaccines, prepared from inactivated local isolates, are used when commercial vaccines are not available or when specific serotypes are involved [<a href="#ref-31">31</a>]. Transcriptomic insights have been used to optimize the cultivation conditions for autogenous vaccine production, ensuring that virulence-associated antigens are expressed during vaccine preparation [<a href="#ref-31">31</a>].
Antimicrobial therapy is used for treatment of clinical outbreaks, but the emergence of antimicrobial resistance (AMR) is a growing concern [<a href="#ref-1">1</a>, <a href="#ref-32">32</a>]. A. salmonicida isolates from Atlantic salmon have shown variable susceptibility to antibiotics, with some strains exhibiting resistance to multiple drug classes [<a href="#ref-32">32</a>]. Genomic characterization of A. salmonicida from pigs has revealed the presence of AMR genes, including those conferring resistance to tetracyclines, beta-lactams, and aminoglycosides [<a href="#ref-1">1</a>]. Mobile genomic islands contribute to the horizontal transfer of resistance genes [<a href="#ref-11">11</a>]. Synergistic combinations of gentamicin, levofloxacin, and cefotaxime have been evaluated in vitro and in vivo against A. salmonicida, showing enhanced efficacy compared to monotherapy [<a href="#ref-33">33</a>].
Phage therapy represents an emerging alternative to antibiotics. Phage TSW001 has been isolated and characterized for its ability to lyse A. salmonicida, and its application on large yellow croaker has shown promise in reducing bacterial loads [<a href="#ref-22">22</a>]. Quorum sensing inhibitors, such as resveratrol, offer another avenue for controlling virulence without exerting selective pressure for resistance [<a href="#ref-18">18</a>].
The following Mermaid diagram illustrates a decision tree for the management of a furunculosis outbreak:
flowchart TD
A["Clinical signs of furunculosis"] --> B{"Confirm diagnosis"}
B --> C["Bacterial culture and PCR"]
C --> D{"Positive for A. salmonicida?"}
D -->|"Yes"| E["Assess outbreak severity"]
D -->|"No"| F["Consider differential diagnoses"]
E --> G{"High mortality?"}
G -->|"Yes"| H["Initiate antimicrobial therapy"]
G -->|"No"| I["Implement biosecurity measures"]
H --> J["Perform antimicrobial susceptibility testing"]
J --> K["Select appropriate antibiotic"]
K --> L["Monitor treatment response"]
L --> M{"Improvement?"}
M -->|"Yes"| N["Continue treatment and vaccinate survivors"]
M -->|"No"| O["Re-evaluate diagnosis and susceptibility"]
I --> P["Vaccinate at-risk populations"]
P --> Q["Implement functional feed additives"]
Q --> R["Monitor for recurrence"]Frequently Asked Questions
What is the primary host range of Aeromonas salmonicida?
The primary host range of A. salmonicida includes salmonid fish such as Atlantic salmon, rainbow trout, and brown trout, but the bacterium also infects non-salmonid species including turbot, sturgeon, grass carp, and large yellow croaker [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-20">20</a>, <a href="#ref-21">21</a>, <a href="#ref-22">22</a>].
How does A. salmonicida cause disease in fish?
A. salmonicida causes disease through a combination of surface-associated virulence factors (A-layer, T3SS, T6SS), secreted enzymes (proteases, hemolysins, GCAT), and quorum sensing-regulated gene expression that collectively facilitate adhesion, tissue invasion, immune evasion, and systemic dissemination [<a href="#ref-8">8</a>, <a href="#ref-14">14</a>, <a href="#ref-15">15</a>, <a href="#ref-16">16</a>, <a href="#ref-18">18</a>].
What are the typical clinical signs of furunculosis?
Typical clinical signs of furunculosis include lethargy, anorexia, darkening of the skin, hemorrhages at fin bases, and the formation of furuncles (necrotic muscle lesions) in chronic cases, while peracute and acute forms present as sudden mortality without external lesions [<a href="#ref-3">3</a>, <a href="#ref-6">6</a>].
How is A. salmonicida diagnosed in a laboratory setting?
A. salmonicida is diagnosed by bacterial culture from kidney or spleen tissue, biochemical profiling (Gram-negative, non-motile, oxidase-positive, fermentative), PCR targeting the 16S rRNA, aroA, or vapA genes, and whole-genome sequencing for strain characterization [<a href="#ref-3">3</a>, <a href="#ref-5">5</a>, <a href="#ref-8">8</a>].
What control strategies are available for furunculosis?
Control strategies for furunculosis include vaccination with commercial or autogenous vaccines, antimicrobial therapy guided by susceptibility testing, biosecurity measures, phage therapy, quorum sensing inhibitors, and immunomodulatory feed additives [<a href="#ref-2">2</a>, <a href="#ref-18">18</a>, <a href="#ref-22">22</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>, <a href="#ref-29">29</a>, <a href="#ref-31">31</a>, <a href="#ref-33">33</a>].
Can A. salmonicida infect mammals?
A. salmonicida has been isolated from pigs and cattle, and a single case of peritonitis in a human undergoing peritoneal dialysis has been reported, but the bacterium is primarily a fish pathogen and mammalian infections are rare and opportunistic [<a href="#ref-1">1</a>, <a href="#ref-7">7</a>, <a href="#ref-23">23</a>].
What is the role of quorum sensing in A. salmonicida virulence?
Quorum sensing in A. salmonicida regulates the expression of virulence factors including proteases and hemolysins in a cell-density-dependent manner, and inhibition of QS by compounds such as resveratrol can attenuate virulence without killing the bacterium [<a href="#ref-18">18</a>].
Are there effective vaccines against furunculosis?
Yes, combined vaccines against vibriosis and typical and atypical furunculosis have been developed and are effective in Atlantic salmon, and autogenous vaccines can be prepared from local isolates when commercial options are not suitable [<a href="#ref-2">2</a>, <a href="#ref-31">31</a>].
What is the significance of mobile genomic islands in A. salmonicida?
Mobile genomic islands, such as GEI-FN1A, contribute to the spread of antibiotic resistance genes among A. salmonicida populations, facilitating the emergence of multidrug-resistant strains [<a href="#ref-11">11</a>].
How does co-infection with other pathogens affect furunculosis?
Co-infection with Flavobacterium psychrophilum in rainbow trout results in synergistic increases in mortality and more severe pathophysiological alterations compared to single infections with either pathogen alone [<a href="#ref-24">24</a>].